Capecitabine is an oral cytotoxic agent that converts into 5-fluorouracil in the body, selectively inhibiting cancer cell growth. It acts more selectively in tumour tissues, reducing systemic toxicity compared to traditional chemotherapy.
Recommended for patients with:
Metastatic or locally advanced breast cancer
Colorectal cancer (colon and rectum)
Gastric adenocarcinoma
Adjuvant treatment after surgery or radiotherapy
In cases where intravenous chemotherapy is not an option
CAPETERO is indicated for the treatment of breast, colorectal and gastrointestinal cancers either as monotherapy or in combination with other chemotherapy agents
Take orally within 30 minutes after meals, twice daily as prescribed. Dosage and duration depend on the type of cancer, stage of disease, and patient's tolerance
Contraindications:
Hypersensitivity to capecitabine or 5-fluorouracil
Severe renal or hepatic impairment
Bone marrow suppression
Pregnancy and breastfeeding
Side Effects:
Nausea, diarrhoea, appetite loss
Hand-foot syndrome, skin reactions
Liver function disorders
Anaemia, leukopenia
Fatigue
